Eric Lev is a seasoned investment professional currently serving as a General Partner at Ampersand Capital Partners since February 2013, focusing on growth-oriented healthcare investments. Eric holds board member positions at several organizations, including BIOLOGOS, P95, iuvo BioScience, Biosynth, ALPCO, and Resolian. Eric previously served on the board of Leinco Technologies, Interpace Biosciences, and Nexelis. Eric earned an MBA from The University of Chicago Booth School of Business and a BA in Economics from Northwestern University, following education at Belmont Hill School.
This person is not in the org chart
This person is not in any teams
This person is not in any offices